STOCK TITAN
  1. Home
  2. Financials
  3. ESSI

Eco Science Financials

ESSI
Source SEC Filings (10-K/10-Q) Data as of Apr 30, 2026 Currency USD FYE January

This page shows Eco Science (ESSI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ESSI FY2026

Outside financing, not operations, is carrying the company while a much lighter liability load slowly repairs the balance sheet.

FY2026 looks materially less encumbered than FY2025 because total liabilities fell from $16.9M to $1.24M. But that balance-sheet cleanup did not create self-funded operations: operating cash flow was still -$368K and financing inflows again had to refill the gap, so the business is still being supported by capital raising rather than by operating cash generation.

Negative equity remains the central structural issue: even after the liability reduction, liabilities still exceed assets by about $1.07M, so the company has improved its balance sheet without yet rebuilding a true asset cushion. Cash liquidity is also thin relative to annual burn; FY2026 cash of $33K covered only a small fraction of the latest operating outflow.

Lower research spending has not meaningfully changed the funding need: R&D declined to $308K in FY2026, yet operating cash outflow still ran near -$368K. That pattern suggests the cash drain is broader than one expense line, which is why modest cost trimming has not translated into a durable improvement in operating cash use.

Generated by Rhea from SEC filings [ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Eco Science's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

Eco Science generated $0 in revenue in fiscal year 2026.

EBITDA
N/A
Net Income
N/A
EPS (Diluted)
$4.37
YoY+956.9%

Eco Science earned $4.37 per diluted share (EPS) in fiscal year 2026. This represents an increase of 956.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$8K
YoY+361.0%
5Y CAGR+26.2%
10Y CAGR-2.3%

Eco Science held $8K in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
25M
YoY-52.9%
5Y CAGR-12.5%
10Y CAGR-2.1%

Eco Science had 25M shares outstanding in fiscal year 2026. This represents a decrease of 52.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
$308K
YoY-7.2%
5Y CAGR+14.3%

Eco Science invested $308K in research and development in fiscal year 2026. This represents a decrease of 7.2% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

ESSI Income Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Revenue $253 N/A $0 $0 $0 N/A $0 $0
Cost of Revenue N/A N/A $0 $0 $0 N/A $0 $0
Gross Profit N/A N/A $0 $0 $0 N/A $0 $0
R&D Expenses $62K N/A $74K-7.3% $80K-18.9% $99K N/A $86K+4.9% $82K
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income -$232K N/A -$226K+7.1% -$243K+4.5% -$254K N/A -$256K-11.3% -$230K
Interest Expense $11K N/A $10K0.0% $10K+3.4% $9K N/A $10K+12.1% $9K
Income Tax $0 N/A $0 N/A $0 N/A $0 N/A
Net Income -$243K N/A -$246K+6.5% -$263K+3.9% -$273K N/A -$275K-10.5% -$249K
EPS (Diluted) $-0.01 N/A $0.00 $0.00+100.0% $-0.13 N/A $-0.01 $0.00

ESSI Balance Sheet

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Total Assets $116K-32.1% $171K+67.6% $102K-2.6% $105K-0.1% $105K-2.4% $107K+3.0% $104K-0.6% $105K
Current Assets $22K-69.5% $71K+3600.3% $2K-58.2% $5K-1.8% $5K-35.8% $7K+77.4% $4K-13.6% $5K
Cash & Equivalents $8K-76.0% $33K+1608.4% $2K-38.2% $3K+82.3% $2K-39.7% $3K-31.3% $4K-13.6% $5K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.4M+15.2% $1.2M-92.9% $17.4M+1.4% $17.2M+1.6% $16.9M+1.6% $16.7M+1.7% $16.4M+1.7% $16.1M
Current Liabilities $1.4M+15.2% $1.2M-92.9% $17.4M+1.4% $17.2M+1.6% $16.9M+1.6% $16.7M+1.7% $16.4M+1.7% $16.1M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$1.3M-22.7% -$1.1M+93.8% -$17.3M-1.4% -$17.1M-1.6% -$16.8M-1.7% -$16.6M-1.7% -$16.3M-1.7% -$16.0M
Retained Earnings -$69.5M-0.4% -$69.3M+12.9% -$79.5M-0.3% -$79.3M-0.3% -$79.0M-0.3% -$78.7M-0.4% -$78.4M-0.4% -$78.2M

ESSI Cash Flow Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Operating Cash Flow -$25K+76.7% -$107K-8.5% -$98K-7.2% -$92K-30.2% -$71K+32.6% -$105K-37.8% -$76K-35.4% -$56K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $0 N/A N/A $0 $0 $0 $0 $0
Financing Cash Flow $0-100.0% $138K+41.4% $97K+4.3% $93K+34.3% $69K-32.9% $104K+37.3% $75K+27.1% $59K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

ESSI Financial Ratios

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin -91790.1% N/A N/A N/A N/A N/A N/A N/A
Net Margin -95959.3% N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -209.2% N/A -241.2%+10.1pp -251.3%+9.9pp -261.2% N/A -264.5%-26.7pp -237.8%
Current Ratio 0.02-0.0 0.06+0.1 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00
Debt-to-Equity -1.09+0.1 -1.16-0.2 -1.010.0 -1.010.0 -1.010.0 -1.010.0 -1.010.0 -1.01
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$1.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Eco Science (ESSI) reported $0 in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Eco Science (ESSI) reported diluted earnings per share of $4.37 for fiscal year 2026. This represents a 956.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Eco Science (ESSI) generated -$368K in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Eco Science (ESSI) had $116K in total assets as of fiscal year 2026, including both current and long-term assets.

Eco Science (ESSI) invested $308K in research and development during fiscal year 2026.

Eco Science (ESSI) had 25M shares outstanding as of fiscal year 2026.

Eco Science (ESSI) had a current ratio of 0.02 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Eco Science (ESSI) had a debt-to-equity ratio of -1.09 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2026 data, Eco Science (ESSI) had $8K in cash against an annual operating cash burn of $368K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Eco Science (ESSI) has negative shareholder equity of -$1.3M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top